Baricitinib tablets bulk supplier for pharma manufacturers

Baricitinib Tablets 2 mg, 4 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 2 mg, 4 mg

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

Category: Arthritis

Baricitinib inhibits Janus kinase (JAK) enzymes, disrupting cytokine signaling involved in inflammation. It effectively reduces symptoms and slows disease progression in rheumatoid arthritis. Benefits include rapid symptom relief, improved joint function, and enhanced quality of life, with convenient oral dosing and a well-established safety profile when monitored properly.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Baricitinib tablets are approved in the EU and US for moderate to severe rheumatoid arthritis. In the EU, Eli Lilly’s Olumiant is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical trial data and biosimilarity assessments. Both regions require detailed dossiers for approval and continuous pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access for baricitinib tablets, ensuring adherence to European and American standards for safe, effective management of autoimmune diseases, helping you navigate complex regulatory landscapes seamlessly.

Baricitinib Tablets — third party manufacturing & bulk supply

Baricitinib Tablets 2 mg, 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Baricitinib Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Baricitinib Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Baricitinib Tablets →

Back to Listing

Frequently Asked Questions

Baricitinib tablets is listed as Tablets in 2 mg, 4 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Baricitinib tablets is referenced against Olumiant®(EU & US- Emergency Use Authorization (EUA). Reference brands are shown for identification only and remain the property of their respective trademark owners.